## **Core Concept**
Ketamine is a medication primarily used for starting and maintaining anesthesia. It induces a trance-like state while providing pain relief, sedation, and memory loss. The core concept here involves understanding the pharmacodynamics of ketamine, specifically its mechanism of action at the receptor level.

## **Why the Correct Answer is Right**
Ketamine acts as an antagonist at the **N-methyl-D-aspartate (NMDA) receptor**. NMDA receptors are a subtype of glutamate receptors, which play a critical role in synaptic plasticity, a cellular mechanism for learning and memory. By blocking NMDA receptors, ketamine disrupts the action of glutamate, leading to its anesthetic, analgesic, and dissociative effects. This mechanism is crucial for its use in clinical settings.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because ketamine's primary mechanism does not involve acting as an agonist at the NMDA receptor; instead, it acts as an antagonist.
- **Option B:** This option is incorrect as there is no well-established primary action of ketamine at this receptor related to its main clinical effects.
- **Option C:** While ketamine can have effects on various receptors, its primary action related to anesthesia is not through this receptor.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that ketamine's dissociative properties, due to its action on NMDA receptors, make it useful not only for anesthesia but also for procedural sedation and analgesia. Additionally, its use has been explored in treatment-resistant depression, highlighting the broad implications of its mechanism of action.

## **Correct Answer:** D. NMDA receptor.